Cardica, Inc.  

(Public, NASDAQ:CRDC)   Watch this stock  
Find more results for CRDC
-0.026 (-9.63%)
Feb 5 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 0.24 - 0.27
52 week 0.11 - 0.66
Open 0.27
Vol / Avg. 389,994.00/712,184.00
Mkt cap 22.66M
P/E     -
Div/yield     -
EPS -0.21
Shares 89.02M
Beta 0.24
Inst. own 54%
May 4, 2016
Q3 2016 Cardica Inc Earnings Release (Estimated) Add to calendar
Feb 4, 2016
Q2 2016 Cardica Inc Earnings Call - Webcast
Feb 4, 2016
Q2 2016 Cardica Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '15) 2015
Net profit margin -614.83% -641.54%
Operating margin -601.46% -628.19%
EBITD margin - -586.22%
Return on average assets -67.78% -49.91%
Return on average equity -709.84% -137.77%
Employees 46 -
CDP Score - -


900 Saginaw Drive
United States - Map
+1-650-3649975 (Phone)
+1-650-3643134 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Cardica Inc. is focused on the commercialization and development of microcutter product line intended for use by surgeons. The Company is engaged in commercializing and developing MicroCutter XCHANGE 30 based on its staple-on-a-strip technology for use by thoracic, pediatric, bariatric, colorectal and general surgeons. Its MicroCutter XCHANGE 30 is a cartridge based microcutter device with around five millimeter shaft diameter and around 30 millimeter staple line cleared for use in the United States for specific indications for use, and in the European Union for a range of indications for use. Its planned products include MicroCutter XCHANGE 45, MicroCutter XCHANGE 60 and MicroCutter FLEXCHANGE 30. The MicroCutter FLEXCHANGE name refers to the planned cartridge-based microcutter product with a flexible shaft that also includes its staple-on-a-strip technology. It markets three products to perform anastomoses, the C-Port xA system, the C-Port Flex A system and the PAS-Port system.

Officers and directors

Julian Nikolchev President, Chief Executive Officer, Director
Age: 60
Bio & Compensation  - Reuters
Robert Y. Newell IV Chief Financial Officer, Vice President - Finance
Age: 65
Bio & Compensation  - Reuters
Thomas J. Palermo Chief Operating Officer
Age: 53
Bio & Compensation  - Reuters
Liam J Burns Vice President - Sales and Marketing
Bio & Compensation  - Reuters
Michael A Bates Director
Bio & Compensation  - Reuters
William P. Moffitt III Independent Director
Bio & Compensation  - Reuters
William H. Younger Jr Independent Director
Age: 65
Bio & Compensation  - Reuters